Align Technology, Inc. $ALGN Stock: IFG Advisory LLC Grows Stake

IFG Advisory LLC grew its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 55,170.0% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,054 shares of the medical equipment provider’s stock after purchasing an additional 11,034 shares during the quarter. IFG Advisory LLC’s holdings in Align Technology were worth $1,463,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the business. K.J. Harrison & Partners Inc purchased a new position in shares of Align Technology during the 2nd quarter worth $1,872,000. Maridea Wealth Management LLC bought a new stake in shares of Align Technology during the 2nd quarter valued at $1,659,000. NewEdge Wealth LLC purchased a new stake in shares of Align Technology in the 2nd quarter worth $1,658,000. Pallas Capital Advisors LLC purchased a new stake in shares of Align Technology in the 2nd quarter worth $1,128,000. Finally, IFP Advisors Inc increased its stake in shares of Align Technology by 8,055.0% in the 3rd quarter. IFP Advisors Inc now owns 57,085 shares of the medical equipment provider’s stock worth $7,561,000 after purchasing an additional 56,385 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Performance

Shares of NASDAQ ALGN opened at $165.98 on Tuesday. The company has a market cap of $11.70 billion, a P/E ratio of 24.16, a P/E/G ratio of 2.16 and a beta of 1.74. Align Technology, Inc. has a 52-week low of $130.23 and a 52-week high of $200.43. The firm’s fifty day moving average is $151.82 and its two-hundred day moving average is $168.57.

Align Technology (NASDAQ:ALGN – Get Free Report) last released its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.77 by $0.03. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The business’s revenue was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.61 EPS. As a group, analysts forecast that Align Technology, Inc. will post 9.21 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Weiss Ratings upgraded Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 9th. Stifel Nicolaus cut their price target on Align Technology from $210.00 to $175.00 and set a “buy” rating for the company in a report on Friday, October 9th. Robert W. Baird cut Align Technology from an “outperform” rating to a “neutral” rating and reduced their price target for the stock from $218.00 to $162.00 in a research report on Thursday, October 15th. Wall Street Zen cut Align Technology from a “buy” rating to a “hold” rating in a research report on Saturday, October 24th. Finally, Zacks Research downgraded Align Technology from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 15th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $193.08.

Read Our Latest Report on Align Technology

Align Technology Profile

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

See Also

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.